Thomas J. Carty

2.1k total citations
41 papers, 1.5k citations indexed

About

Thomas J. Carty is a scholar working on Pharmacology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Thomas J. Carty has authored 41 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pharmacology, 9 papers in Molecular Biology and 8 papers in Organic Chemistry. Recurrent topics in Thomas J. Carty's work include Inflammatory mediators and NSAID effects (12 papers), Eicosanoids and Hypertension Pharmacology (7 papers) and Estrogen and related hormone effects (6 papers). Thomas J. Carty is often cited by papers focused on Inflammatory mediators and NSAID effects (12 papers), Eicosanoids and Hypertension Pharmacology (7 papers) and Estrogen and related hormone effects (6 papers). Thomas J. Carty collaborates with scholars based in United States, Japan and United Kingdom. Thomas J. Carty's co-authors include James D. Eskra, Robert H. Abeles, José R. Perez, Laurent Audoly, Catherine E. Trebino, Bernard Babior, Francis J. Sweeney, Joseph G. Lombardino, Brian Naiman and Per‐Johan Jakobsson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Thomas J. Carty

37 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas J. Carty United States 21 609 561 214 201 201 41 1.5k
Elizabeth Wong Canada 23 740 1.2× 414 0.7× 124 0.6× 491 2.4× 247 1.2× 44 1.7k
Carina L. Bos Netherlands 14 267 0.4× 473 0.8× 168 0.8× 105 0.5× 87 0.4× 17 1.4k
Wanda Cromlish Canada 25 722 1.2× 925 1.6× 42 0.2× 392 2.0× 220 1.1× 34 2.1k
David Claveau Canada 15 505 0.8× 416 0.7× 47 0.2× 255 1.3× 118 0.6× 29 1.1k
Shiro Nakaike Japan 23 163 0.3× 414 0.7× 219 1.0× 214 1.1× 134 0.7× 77 1.6k
Chi‐Chung Chan Canada 25 1.2k 2.0× 1.0k 1.8× 106 0.5× 709 3.5× 296 1.5× 41 2.7k
Akinori Arimura Japan 24 322 0.5× 456 0.8× 155 0.7× 249 1.2× 57 0.3× 67 2.2k
S. Charleson Canada 25 1.0k 1.7× 770 1.4× 76 0.4× 505 2.5× 339 1.7× 51 2.7k
Tsumoru Miyamoto Japan 16 670 1.1× 489 0.9× 31 0.1× 183 0.9× 406 2.0× 22 1.7k
John P. Umland United States 14 439 0.7× 509 0.9× 48 0.2× 144 0.7× 80 0.4× 17 1.2k

Countries citing papers authored by Thomas J. Carty

Since Specialization
Citations

This map shows the geographic impact of Thomas J. Carty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas J. Carty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas J. Carty more than expected).

Fields of papers citing papers by Thomas J. Carty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas J. Carty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas J. Carty. The network helps show where Thomas J. Carty may publish in the future.

Co-authorship network of co-authors of Thomas J. Carty

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas J. Carty. A scholar is included among the top collaborators of Thomas J. Carty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas J. Carty. Thomas J. Carty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Noe, Mark C., Peter G. Mitchell, Lori Lopresti‐Morrow, et al.. (2005). Discovery of 3,3-dimethyl-5-hydroxypipecolic hydroxamate-based inhibitors of aggrecanase and MMP-13. Bioorganic & Medicinal Chemistry Letters. 15(11). 2808–2811. 29 indexed citations
2.
Noe, Mark C., Peter G. Mitchell, Lori Lopresti‐Morrow, et al.. (2005). Discovery of 3-OH-3-methylpipecolic hydroxamates: Potent orally active inhibitors of aggrecanase and MMP-13. Bioorganic & Medicinal Chemistry Letters. 15(14). 3385–3388. 26 indexed citations
3.
Trebino, Catherine E., et al.. (2005). Redirection of Eicosanoid Metabolism in mPGES-1-deficient Macrophages. Journal of Biological Chemistry. 280(17). 16579–16585. 83 indexed citations
4.
Dombroski, Mark A., Michael A. Letavic, Kim F. McClure, et al.. (2004). Benzimidazolone p38 inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(4). 919–923. 22 indexed citations
5.
Letavic, Michael A., Thomas J. Carty, Joel R. Hardink, et al.. (2003). Synthesis and biological activity of piperazine-Based dual MMP-13 and TNF-α converting enzyme inhibitors. Bioorganic & Medicinal Chemistry Letters. 13(19). 3243–3246. 29 indexed citations
6.
Sweeney, Francis J., James D. Eskra, Ralph H. Lambalot, et al.. (2003). Inhibition of IL-1β-dependent prostaglandin E2 release by antisense microsomal prostaglandin E synthase 1 oligonucleotides in A549 cells. Molecular and Cellular Endocrinology. 205(1-2). 151–157. 16 indexed citations
7.
Carty, Thomas J.. (2001). Hartford's Catholic Legacy: Leadership (review). ˜The œCatholic historical review. 87(3). 531–533. 1 indexed citations
8.
Carty, Thomas J., et al.. (1999). New Insights into Disintegrin Metalloproteases. Inflammation Research. 48(5). 229–231. 6 indexed citations
9.
Carty, Thomas J., Francis J. Sweeney, R. Griffiths, et al.. (1997). Tenidap inhibits 5-lipoxygenase product formation in vitro, but this activity is not observed in three animal models. Inflammation Research. 46(5). 168–179. 6 indexed citations
10.
Moore, Peter F., David Larson, Ivan G. Otterness, et al.. (1996). Tenidap, a structurally novel drug for the treatment of arthritis: Antiinflammatory and analgesic properties. Inflammation Research. 45(2). 54–61. 29 indexed citations
11.
Carty, Thomas J., et al.. (1995). The biochemistry and pharmacology of TNFα andβ, 21 April 1995, New York. Inflammation Research. 44(11). 455–457. 1 indexed citations
12.
O’Connor, Brian, S. Uden, Thomas J. Carty, et al.. (1994). Inhibitory Effect of UK,74505, a Potent and Specific Oral Platelet Activating Factor (PAF) Receptor Antagonist, on Airway and Systemic Responses to Inhaled PAF in Humans. American Journal of Respiratory and Critical Care Medicine. 150(1). 35–40. 25 indexed citations
13.
Perregaux, David G., et al.. (1992). IL-1 beta maturation: evidence that mature cytokine formation can be induced specifically by nigericin. The Journal of Immunology. 149(4). 1294–1303. 115 indexed citations
14.
Blackburn, Warren D., Louis W. Heck, Leland D. Loose, James D. Eskra, & Thomas J. Carty. (1991). Inhibition of 5‐lipoxygenase product formation and polymorphonuclear cell degranulation by tenidap sodium in patients with rheumatoid arthritis. Arthritis & Rheumatism. 34(2). 204–210. 49 indexed citations
15.
Mylari, Banavara L., Thomas J. Carty, Peter F. Moore, & William J. Zembrowski. (1990). 1,2-Dihydro-1-oxopyrrolo[3,2,1-kl]phenothiazine-2-carboxamides and congeners, dual cyclooxygenase/5-lipoxygenase inhibitors with anti-inflammatory activity. Journal of Medicinal Chemistry. 33(7). 2019–2024. 25 indexed citations
16.
Carty, Thomas J. & Ronald E. Laliberte. (1989). The biochemistry and pharmacology of interleukins-1 and -6. Inflammation Research. 26(3-4). 391–393. 7 indexed citations
17.
Sweeney, Francis J., James D. Eskra, Michael J. Ernest, & Thomas J. Carty. (1987). Spectrophotometric monitoring of lipoxygenase and cyclooxygenase pathway activity using ionophore stimulated whole blood. Inflammation Research. 21(3-4). 393–396. 13 indexed citations
18.
Carty, Thomas J., James D. Eskra, Joseph G. Lombardino, & William W. Hoffman. (1980). Piroxicam, a potent inhibitor of prostaglandin production in cell culture. Structure-activity study. Prostaglandins. 19(1). 51–59. 60 indexed citations
19.
Eskra, James D., Lawrence Levine, & Thomas J. Carty. (1980). Preparation of [3H]-12-L-hydroxyeicosatetraenoic acid and its use in radioimmunoassay. Prostaglandins and Medicine. 5(3). 201–207. 3 indexed citations
20.
Carty, Thomas J., Bernard Babior, & Robert H. Abeles. (1971). The Mechanism of Action of Ethanolamine Ammonia-Lyase, a B12-dependent Enzyme. Journal of Biological Chemistry. 246(20). 6313–6317. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elizabeth Wong Breakdown of academic impact, for papers by Carina L. Bos Breakdown of academic impact, for papers by Wanda Cromlish Breakdown of academic impact, for papers by David Claveau Breakdown of academic impact, for papers by Shiro Nakaike Breakdown of academic impact, for papers by Chi‐Chung Chan Breakdown of academic impact, for papers by Akinori Arimura Breakdown of academic impact, for papers by S. Charleson Breakdown of academic impact, for papers by Tsumoru Miyamoto Breakdown of academic impact, for papers by John P. Umland
Rankless by CCL
2026